1
Graham E Martin, Ian D Cockshott, Francis J T Fildes: Fibrillar product. Imperial Chemical, Cushman Darby & Cushman, November 7, 1989: US04878908 (89 worldwide citation)

The disclosure relates to a prosthetic device and method for repairing a damaged blood vessel comprising a mat of fibers adjacent the bore of a tube having a disposition substantially parallel to the inner surface of the tube, the mat having a thickness of 0.5 mm to 5 mm.


2
John R Evans, Francis J T Fildes, Jean E Oliver: Process for preparing freeze-dried liposome compositions. Imperial Chemical, Cushman Darby & Cushman, January 25, 1983: US04370349 (60 worldwide citation)

Process for preparing a freeze-dried, potential liposome, mixture which comprises either (a) dissolving at least one liposome-forming amphipathic lipid, at least one biologically-active compound, and optionally one or more adjuvants, in a suitable solvent, and then freeze-drying the solution, or (b) ...


3
Francis J T Fildes, Francis G Hutchinson: Delivery means for biologically active agents. Imperial Chemical, Cushman Darby & Cushman, November 25, 1980: US04235988 (51 worldwide citation)

A sustained release delivery means comprising a biologically active agent and a hydrophilic linear block poly oxyalkylene- polyurethane copolymer.


4
John R Evans, Francis J T Fildes, Jean E Oliver: Process for preparing freeze-dried liposome compositions. Imperial Chemical, Cushman Darby & Cushman, January 19, 1982: US04311712 (51 worldwide citation)

Process for preparing a freeze-dried, potential liposome, mixture which comprises either (a) dissolving at least one liposome-forming amphipathic lipid, at least one biologically-active compound, and optionally one or more adjuvants, in a suitable solvent, and then freeze-drying the solution, or (b) ...


5
Francis J T Fildes, Francis G Hutchinson: Delivery means for biologically active agents comprising hydrophilic polyurethane. Imperial Chemical, Cushman Darby & Cushman, May 13, 1980: US04202880 (31 worldwide citation)

Sustained release delivery means comprising (i) a biologically active agent, (ii) a linear hydrophilic block polyoxyalkylene-polyurethane copolymer, and (iii) optionally containing a buffer. Included among the biologically active agents are abortifacient compounds.